2022-08-31| InterviewsSpecial

Scaling up Korea’s Biotech Presence in The Global Value Chain, an Interview with Seung Kyou Lee, Vice President of KoreaBIO

by Reed Slater
Share To
South Korea’s remarkable industrial and economic growth in the last century has pushed it into one of the top-ranking positions in the world. Electronics manufacturing and steel production spearheaded the country’s rise to prosperity, and in recent years, its emerging biotechnology industry is proving to be another huge step in the country’s evolution. Companies like Samsung, Celltrion, and SK Bioscience have made Korea one of the leading countries in Asia in the biotech industry. 
At BIOPLUS-INTERPHEX (BIX) Korea 2022 in Seoul, an annual conference bringing together biotech industry professionals from around the world, Vice President of KoreaBIO, Seung Kyou Lee, sat down and highlighted Korean biotech’s most promising and exciting trends. Lee covered everything from connecting in person again, the current and hopeful future state of the Korean biotech industry, and what it might take for Korea to take a more prominent position on the global stage.123

It's free! Log in now to read

Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
Scroll to Top